Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Substance Name: MEDI 551
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
[Neuromyelitis optica spectrum disorder: a case report].
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis.
The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects.
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Acid-sensing ion channels: trafficking and synaptic function.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
[Symptoms of circadian desynchronization in patients with multiple sclerosis.]
Heat shock protein 27 in multiple sclerosis relapses.

Pages